These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25516646)

  • 1. Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.
    Rossi RE; Parisi I; Despott EJ; Burroughs AK; O'Beirne J; Conte D; Hamilton MI; Murray CD
    World J Gastroenterol; 2014 Dec; 20(46):17352-9. PubMed ID: 25516646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
    Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
    J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.
    Kok B; Lester ELW; Lee WM; Hanje AJ; Stravitz RT; Girgis S; Patel V; Peck JR; Esber C; Karvellas CJ;
    Dig Dis Sci; 2018 Jun; 63(6):1654-1666. PubMed ID: 29564668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.
    Rodrigues S; Lopes S; Magro F; Cardoso H; Horta e Vale AM; Marques M; Mariz E; Bernardes M; Lopes J; Carneiro F; Macedo G
    World J Gastroenterol; 2015 Jun; 21(24):7584-8. PubMed ID: 26140007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.
    Koller T; Galambosova M; Filakovska S; Kubincova M; Hlavaty T; Toth J; Krajcovicova A; Payer J
    World J Gastroenterol; 2017 Jun; 23(22):4102-4111. PubMed ID: 28652663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
    Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miscellaneous adverse events with biologic agents (excludes infection and malignancy).
    Feuerstein JD; Cheifetz AS
    Gastroenterol Clin North Am; 2014 Sep; 43(3):543-63. PubMed ID: 25110258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature].
    Rösner S; Schad A; Kittner J; Rahman F; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Z Gastroenterol; 2014 Jan; 52(1):58-63. PubMed ID: 24420801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.
    Parisi I; O'Beirne J; Rossi RE; Tsochatzis E; Manousou P; Theocharidou E; Hamilton M; Murray C; Epstein O; Burroughs AK
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):786-91. PubMed ID: 27015138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of infliximab on paracetamol-induced hepatotoxicity in rats.
    Ferah I; Halici Z; Bayir Y; Demirci E; Unal B; Cadirci E
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):373-81. PubMed ID: 23496246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
    Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
    Sandhu A; Alameel T; Dale CH; Levstik M; Chande N
    Aliment Pharmacol Ther; 2012 Jul; 36(2):159-65. PubMed ID: 22616981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.
    Lopetuso LR; Mocci G; Marzo M; D'Aversa F; Rapaccini GL; Guidi L; Armuzzi A; Gasbarrini A; Papa A
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel Disease.
    Núñez F P; Quera R; Bay C; Castro F; Mezzano G
    J Crohns Colitis; 2022 Aug; 16(7):1168-1176. PubMed ID: 35044449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of agents used in the management of inflammatory bowel disease.
    Khokhar OS; Lewis JH
    Dig Dis; 2010; 28(3):508-18. PubMed ID: 20926880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
    Cullen G; Kroshinsky D; Cheifetz AS; Korzenik JR
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1318-27. PubMed ID: 21957906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury.
    Kuhla A; Eipel C; Abshagen K; Siebert N; Menger MD; Vollmar B
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1069-76. PubMed ID: 19264954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections.
    Temel T; Cansu DÜ; Korkmaz C; Kaşifoğlu T; Özakyol A
    Int J Rheum Dis; 2015 Jan; 18(1):40-5. PubMed ID: 25195983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
    Tukov FF; Luyendyk JP; Ganey PE; Roth RA
    Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.